ArticleEarly human development2015
Treatment of supraventricular tachycardia in infants: Analysis of a large multicenter database.
Article in Early human development, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 63 citations in OpenAlex.
- Neonatal and Infant Health Outcomes Following Maternal COVID-19 Vaccination: CDC's COVID-19 Vaccine Pregnancy Registry.Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners · 2026Article
- Clinical practice guidelines: management of non-post-operative supra-ventricular tachycardia in neonates and children less than 18 years old hospitalized in a Pediatric Intensive Care Unit.Annals of intensive care · 2026Article
- Trends, gender, and racial disparities in patients with mortality due to paroxysmal tachycardia: A nationwide analysis from 1999-2020.PloS one · 2025Article
- Amiodarone and Adenosine for Pediatric Supraventricular Tachycardia: A Systematic Review.Cureus · 2023Review
- Transesophageal pacing studies reduce readmission but prolong initial admission in infants with supraventricular tachycardia: A cost-comparison analysis.Heart rhythm O2 · 2023Article
- Assessing the Risk of Hypoglycemia Secondary to Propranolol Therapy for the Treatment of Supraventricular Tachycardia in Infants.Pediatric cardiology · 2023Article
- Effective Control of Supraventricular Tachycardia in Neonates May Requires Combination Pharmacologic Therapy.Journal of clinical medicine · 2022Article
- Medical Management of Infants With Supraventricular Tachycardia: Results From a Registry and Review of the Literature.CJC pediatric and congenital heart disease · 2022Article
- Fetal Intervention for Refractory Supraventricular Tachycardia Complicated by Hydrops Fetalis.Case reports in obstetrics and gynecology · 2022Article
- Supraventricular tachycardias in neonates and infants: factors associated with fatal or near-fatal outcome.European journal of pediatrics · 2021Article
- Feasibility of P wave Centric Ambulatory Electrocardiogram Monitoring in Infants and Young Children.Pediatric cardiology · 2021Article
- Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre.BMC cardiovascular disorders · 2021Observational
- Care of Children with Supraventricular Tachycardia in the Emergency Department.Pediatric cardiology · 2021Article
- [Paediatric Life Support].Notfall & rettungsmedizin · 2021Review
- Incessant Automatic Atrial Tachycardia in a Neonate Successfully Treated with Nadolol and Closely Spaced Doses of Flecainide: A Case Report.Pediatric reports · 2020Article
- Fetal Tachycardia in the Delivery Room: Fetal Distress, Supraventricular Tachycardia, or Both?AJP reports · 2020Article
- Furosemide Exposure and Prevention of Bronchopulmonary Dysplasia in Premature Infants.The Journal of pediatrics · 2019Article
- OUTCOME OF SUPRAVENTRICULAR TACHYCARDIA IN INFANCY AFTER 4-YEAR FOLLOW-UP.The Ulster medical journal · 2018Article
- Postnatal Outcomes of Fetal Supraventricular Tachycardia: a Multicenter Study.Pediatric cardiology · 2017Article
- Antihypertensive drug exposure in premature infants from 1997 to 2013.Cardiology in the young · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
Abstract
objectiveSupraventricular tachycardia (SVT) is the most common arrhythmia in infants. Infants are typically treated with antiarrhythmic medications, but there is a lack of evidence guiding management, thus exposing infants to risks of both inadequate therapy and medication adverse events. We used data from a large clinical database to better understand current practices in SVT management, safety of commonly used medications, and outcomes of hospitalized infants treated for SVT.
methodsThis retrospective data analysis included all infants discharged from Pediatrix Medical Group neonatal intensive care units between 1998 and 2012 with a diagnosis of SVT who were treated with antiarrhythmic medications. We categorized infants by the presence of congenital heart disease other than patent ductus arteriosus. Medications were categorized as abortive, acute, or secondary prevention therapies. We used descriptive statistics to describe medication use, adverse events, and outcomes including SVT recurrence and mortality.
resultsA total of 2848 infants with SVT were identified, of whom 367 (13%) had congenital heart disease. Overall, SVT in-hospital recurrence was high (13%), and almost one fifth of our cohort (18%) experienced an adverse event. Mortality was 2% in the overall cohort and 6% in the congenital heart disease group (p<0.001). Adenosine was the most commonly used abortive therapy, but there was significant practice variation in therapies used for acute treatment and secondary prevention of SVT. CONCLUSION AND PRACTICE IMPLICATION: Significant variation in SVT treatment and suboptimal outcomes warrant future clinical trials to determine best practices in treating SVT in infants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.